EP3390395
Efnasambönd sem eru gagnleg sem kínasahemlar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.12.2016EP published:
9.9.2020EP application number:
16816363.2
EP translation filed:
8.10.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
15.12.2036Expiry date:
15.12.2026Next due date:
31.12.2026
Title:
COMPOUNDS USEFUL AS KINASE INHIBITORS
Timeline
Today
16.12.2016EP application
9.9.2020EP Publication
8.10.2020Translation submitted
15.11.2020Registration published
15.12.2026Expires
Owner
Name:
Loxo Oncology, Inc.Address:
Lilly Corporate Centre Indianapolis, Indiana 46285, US
Inventor
Name:
GUISOT, NicolasAddress:
Alderley Edge Cheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201522245Date:
16.12.2015Country:
GB
Number:
201613945Date:
15.8.2016Country:
GB
Supplementary protection
SPC number:
SPC456
Classification
Categories:
C07D 405/14, A61K 31/415, A61K 31/4155, C07D 231/14, C07D 401/04, C07D 401/06, C07D 403/04, C07D 405/04, C07D 405/06, C07D 405/08, C07D 413/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.11.2020
Expires: 15.12.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 17.11.2021
Expires: 15.12.2022
Payer: Patice ehf.
Number: 7
Paid: 22.11.2022
Expires: 15.12.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.12.2023
Expires: 15.12.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.11.2024
Expires: 15.12.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.12.2025
Expires: 15.12.2026
Payer: Árnason Faktor ehf.